Created in 2011 (United States), THINK OUTSIDE THE VEIN own 3 sister brands and 2214 competing brands. The THINK OUTSIDE THE VEIN brand is owned by Halozyme Therapeutics, a company listed in New York. THINK OUTSIDE THE VEIN is part of the Biotechnology activity sector.

THINK OUTSIDE THE VEIN is a brand of Halozyme Therapeutics (HALO) Share price

International deposit : 2011 Business sector Biotechnology

Share price and profitability of the share Halozyme Therapeutics (THINK OUTSIDE THE VEIN)

Buy Halozyme Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 39.12

Portfolio valuation
Halozyme Therapeutics (THINK OUTSIDE THE VEIN) over 5 years* USD 94.06

Stock market history Halozyme Therapeutics (THINK OUTSIDE THE VEIN)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Halozyme Therapeutics

See more brands of Halozyme Therapeutics

Rival brands
THINK OUTSIDE THE VEIN

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS